Age-related Hearing Loss and Lexical Disorders

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

46 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-08-27

Study Completion Date

2019-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In France, Alzheimer's disease accounts for 70 to 80% of the causes of neurocognitive disorders, i.e. 600,000 to 800,000 patients. It is a neurodegenerative pathology that causes evolutionary cognitive dysfunction, mainly affecting memory functions. The inability to name familiar objects (lack of the word) is one of the most commonly noted symptoms at an early stage of the disease.

Presbyacusis, or age-related hearing loss, is the most common sensory deficit in the elderly which is manifested socially by a progressive discomfort of verbal communication. Presbyacusis remains underdiagnosed and undertreated: 2/3 of the patients are not using hearing aid.

In recent years, a link between neurocognitive disorders and hearing loss has been shown by investigating general cognition. In this study, the investigators are investigating lexical disorders.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Auditory Rehabilitation and Cognition in Alzheimer Patients

NCT03002142

Alzheimer's Disease Hearing Loss

COMPLETED NA

Association Between Cognitive Impairment and the Presence of Hearing Problems and Precarious Conditions

NCT06478888

Cognitive Dysfunction

NOT_YET_RECRUITING

Hearing Loss and Genetic Risks for Alzheimer's Disease and Related Dementia

NCT07288463

Hearing Loss, Adult-Onset Dementia

NOT_YET_RECRUITING NA

Validation of acceXible's Automated Speech Analysis Method for the Early Detection and Monitoring of Patients With Mild Impairment or Dementia in Primary Care

NCT05380297

Mild Cognitive Impairment Dementia

UNKNOWN NA

Longitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease.

NCT03851523

Alzheimer Disease Mild Cognitive Impairment Subjective Cognitive Decline

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer Disease Presbycusis Lexical Syntactic Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LOOP group

Speech therapy consultation for patients with Alzheimer's disease

Speech therapy

Intervention Type OTHER

During a 1-hour speech-language consultation, a lack of word evaluation will be conducted and patient will answer a Hearing Difficulty Questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Speech therapy

During a 1-hour speech-language consultation, a lack of word evaluation will be conducted and patient will answer a Hearing Difficulty Questionnaire

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \> 65 years old
* French mother tongue
* Good vision with or without correction
* Alzheimer's or related disease (15 \<Mini-Mental State Examination\<25)
* Affiliate or beneficiary of a social security
* Informed consent

Exclusion Criteria

* Cognitive disorders related to another pathology (cerebrovascular accident, head trauma, epilepsy ...)
* Protected patient (under guardianship) or person deprived of liberty by judicial or administrative decision

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No